Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461641 · ClinicalTrials.gov registry record · NA
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
A NA study, sponsored by NuTech Medical.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT02461641 is a NA study that has completed, run by NuTech Medical. The registered enrollment target is 96 participants.
The verdict
NCT02461641, a NA study, has completed, sponsored by NuTech Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study was designed to determine the heal rate of diabetic foot ulcers at 4 weeks, and complete closure at 8 and 12 weeks of patients treated with either NuShield or Affinity compared to standard care alone.
Interventions
- OTHER Standard of Care
- OTHER NuShield
- OTHER Affinity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02461641
The ClinicalTrials.gov registry entry for NCT02461641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuTech Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT02461641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02461641 about?
NCT02461641 is a clinical study titled "NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers". This study was designed to determine the heal rate of diabetic foot ulcers at 4 weeks, and complete closure at 8 and 12 weeks of patients treated with either NuShield or Affinity compared to standard care alone.
What is the current status of trial NCT02461641?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2015-03. Estimated completion is 2018-10-25.
What interventions are being tested in trial NCT02461641?
The interventions under investigation include: Standard of Care (OTHER), NuShield (OTHER), Affinity (OTHER).
Who is sponsoring clinical trial NCT02461641?
This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.